References
- Eliakim M, Sadovsky E, Stein O, Shenkar YG. Recurrent cholestatic jaundice of pregnancy: a report of five cases and electron microscopic observations. Arch Intern Med 1966;117:696–705.
- Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996; 175:957–60.
- Fisk NM, Sotrey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988;95:1137–43.
- Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994;170:890–5.
- Berg B, Helm G, Petersohn L, Tryrding N. Cholestasis of pregnancy: clinical and laboratory studies. Acta Obstet Gynecol Scand 1986;65:107–13.
- Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Sem Liver Dis 1993;13:289–301.
- Hirvioja ML, Kivinen S. Inheritance of intrahepatic cholestasis of pregnancy in one kindred. Clin Genet 1993;43:315–7.
- Holzbach RT, Sivak DA, Braun WE. Familial recurrent intrahepatic cholestasis of pregnancy, a genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology 1983;85:175–9.
- Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel S. Heterozygous non-sense mutation of the MDR3gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353: 210–1.
- Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999;8:1913–23.
- Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-conenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998;178: 603–8.
- Iljst L, Ruiter JPN, Hoovers JMN, Jakobs ME, Wanders RJA. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency—characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional alpha subunit gene. J Clin Invest 1996;98: 1028–33.
- Yang B-H, Heng H, Ding J-H, Roe C. The genes for the α and β subunits of the mitochondrial trifunctional protein are both located in the same region of human chromosome 2p23. Genomics 1996;37: 141–3.
- Vandenplas S, Wiid I, Grobler-Rabie A, Brebner K, Ricketts M, Wallis G, et al. Blot hybridization of genomic DNA. J Med Genet 1984;21:164–72.
- Sheffield VC, Weber JL, Buetow KH, Murray JC, Even DA, Wiles JM, et al. A collection of tri- and tetranucleotide repeat markers used to generate high quality, high resolution human genome-wide linkage maps. Hum Mol Genet 1995;4:1837–44.
- Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999;94:189–93.
- Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet 1999;23:397–404.
- Watanabe S, Phillips MJ. Acute phalloidin toxicity in living hepatocytes. Evidence for a possible disturbance in membrane flow and for multiple functions for actin in the liver cell. Am J Pathol 1986;122:101–11.
- Hsu CY, Frankel FR. Effect of estrogen on the expression of mRNAs of different actin isoforms in immature rat uterus. Cloning of alpha-smooth muscle actin message. J Biol Chem 1987;262:9594–600.
- Reyes-Romero MA. Are changes in expression of actin genes involved in estrogen-induced cholestasis. Med Hypothesis 1990; 32:39–43.
- Mella JG, Roschmann E, Glasinovic JC, Alvarado A, Scrivanti M, Volk BA. Exploring the genetic role of the HLA-DPB1 locus in Chileans with intrahepatic cholestasis of pregnancy. J Hepatol 1996;24:320–3.
- Watanabe S, Miyairi M, Oshio C, Smith CR, Phillips MJ. Phal- loidin alters bile canalicular contractility in primary monolayer cultures of rat liver. Gastroenterology 1983;85: 245–53.
- Rost D, Kartenbeck J, Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin- induced cholestasis. Hepatology 1999;29: 814–21.
- Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 1997;26:1573–9.
- Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000;9:1209–17.
- Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000;118:163–72.
- Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000;118:422–30.
- Liu Y, Huang L, Hoffman T, Gosland M, Vore M. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver. Cancer Res 1996;56: 4992–7.
- Arngrimsson R, Sigurardottir S, Frigge ML, Bjarnadottir RI, Jonsson T, Stefansson H, et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999;8:1799–805.